logo

Stealth Biotherapeutics Corp (MITO)



Trade MITO now with
  Date
  Headline
4/6/2021 7:44:21 AM Stealth BioTherapeutics FY Loss Per Share $0.10 Vs Loss $0.19 Last Year
3/16/2021 7:32:20 AM Stealth BioTherapeutics Promotes Marty Redmon To Chief Research & Development Officer
2/23/2021 7:39:39 AM Stealth Completes Enrollment Of Phase 2 Study In Dry Age-Related Macular Degeneration With Geographic Atrophy
2/10/2021 7:58:16 AM Stealth BioTherapeutics Reports Pricing Of $4.7 Mln Direct Offering Of ADS
1/5/2021 8:04:49 PM Stealth Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome
8/6/2020 7:41:50 AM Stealth BioTherapeutics Q2 Net Loss $12.4 Mln Or $0.02/shr Vs. Net Loss $15.8 Mln Or $0.04/shr Last Year
4/13/2020 8:26:47 AM Stealth Biotherapeutics Announces $20 Mln Financing
4/1/2020 7:32:07 AM Stealth BioTherapeutics FY Loss Per Share $0.19 Vs Loss $1.41 Last Year
3/3/2020 7:32:42 AM Stealth BioTherapeutics: FDA Grants Rare Pediatric Disease Designation For Elamipretide For Barth Syndrome
1/21/2020 7:34:14 AM Stealth BioTherapeutics Initiates First-in-Human Study Of SBT-272